Home > Compound List > Compound details
92339-11-2 molecular structure
click picture or here to close

5-{N-[3-(N-{3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl}acetamido)-2-hydroxypropyl]acetamido}-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide

ChemBase ID: 1118
Molecular Formular: C35H44I6N6O15
Molecular Mass: 1550.18188
Monoisotopic Mass: 1549.71330274
SMILES and InChIs

SMILES:
Ic1c(N(CC(O)CN(c2c(I)c(c(I)c(c2I)C(=O)NCC(O)CO)C(=O)NCC(O)CO)C(=O)C)C(=O)C)c(I)c(c(I)c1C(=O)NCC(O)CO)C(=O)NCC(O)CO
Canonical SMILES:
OCC(CNC(=O)c1c(I)c(N(C(=O)C)CC(CN(c2c(I)c(C(=O)NCC(CO)O)c(c(c2I)C(=O)NCC(CO)O)I)C(=O)C)O)c(c(c1I)C(=O)NCC(CO)O)I)O
InChI:
InChI=1S/C35H44I6N6O15/c1-13(52)46(30-26(38)20(32(59)42-3-15(54)9-48)24(36)21(27(30)39)33(60)43-4-16(55)10-49)7-19(58)8-47(14(2)53)31-28(40)22(34(61)44-5-17(56)11-50)25(37)23(29(31)41)35(62)45-6-18(57)12-51/h15-19,48-51,54-58H,3-12H2,1-2H3,(H,42,59)(H,43,60)(H,44,61)(H,45,62)
InChIKey:
NBQNWMBBSKPBAY-UHFFFAOYSA-N

Cite this record

CBID:1118 http://www.chembase.cn/molecule-1118.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
5-{N-[3-(N-{3,5-bis[(2,3-dihydroxypropyl)carbamoyl]-2,4,6-triiodophenyl}acetamido)-2-hydroxypropyl]acetamido}-1-N,3-N-bis(2,3-dihydroxypropyl)-2,4,6-triiodobenzene-1,3-dicarboxamide
IUPAC Traditional name
iodixanolum
iodixanol
Brand Name
Visipaque
Visipaque 270
Visipaque 320
Synonyms
Indixanol
Iodixanolum
Iodixanol
5,5'-[(2-Hydroxy-1,3-propanediyl)bis(acetylimino)]bis[N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide
2-5410-3A
OptiPrep
Visipaque
Iodixanol solution
OptiPrep™ Density Gradient Medium
CAS Number
92339-11-2
MDL Number
MFCD00867965
PubChem SID
160964581
46504687
PubChem CID
3724

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem ALOGPS 2.1
Acid pKa 11.433949  H Acceptors 15 
H Donor 13  LogD (pH = 5.5) -2.0626314 
LogD (pH = 7.4) -2.0626664  Log P -2.062631 
Molar Refractivity 277.1619 cm3 Polarizability 107.42674 Å3
Polar Surface Area 339.09 Å2 Rotatable Bonds 22 
Lipinski's Rule of Five false 
Log P -2.91  LOG S -3.92 
Solubility (Water) 1.85e-01 g/l 

PROPERTIES

PROPERTIES

Physical Property Safety Information Product Information Bioassay(PubChem)
Solubility
0.185 mg/mL [Predicted by ALOGPS] expand Show data source
Methanol expand Show data source
Water expand Show data source
Apperance
White Solid expand Show data source
Melting Point
262-267°C (dec.) expand Show data source
Hydrophobicity(logP)
0.5 expand Show data source
Storage Condition
Refrigerator expand Show data source
MSDS Link
Download expand Show data source
German water hazard class
1 expand Show data source
Certificate of Analysis
Download expand Show data source

DETAILS

DETAILS

DrugBank DrugBank Sigma Aldrich Sigma Aldrich TRC TRC
DrugBank - DB01249 external link
Item Information
Drug Groups approved
Description Iodixanol is a nonionic hydrophilic compound commonly used as a contrast agent during coronary angiography, particularly in individuals with renal dysfunction, as it is believed to be less toxic to the kidneys than most other intravascular contrast agents.
Indication Iodixanol is a contrast agent during coronary angiography.
Pharmacology Iodixanol is a contrast agent commonly used during coronary angiography, particularly in individuals with renal dysfunction, as it is believed to be less toxic to the kidneys than most other intravascular contrast agents. It is an iso-osmolar contrast agent, with an osmolality of 290 mOsm/kg H20, the same as blood.
Toxicity Non-ionic radiocontrast agents like iodixanol are cytotoxic to renal cells. The toxic effects include apoptosis, cellular energy failure, disruption of calcium homeostasis, and disturbance of tubular cell polarity, and are thought to be linked to oxidative stress.
Affected Organisms
Humans and other mammals
Biotransformation Excreted unchanged
Half Life 2.1 hours. In patients with significantly impaired renal function (mean creatinine clearance rate, 9.91 [± 3.58] mL per minute), the plasma half-life is increased to 23 hours.
Protein Binding Negligible
Elimination In adults, approximately 97% of the injected dose of iodixanol is excreted unchanged in urine within 24 hours, with less than 2% excreted in feces within five days post-injection.
Distribution * 0.26 L/kg
References
Spencer CM, Goa KL: Iodixanol. A review of its pharmacodynamic and pharmacokinetic properties and diagnostic use as an x-ray contrast medium. Drugs. 1996 Dec;52(6):899-927. [Pubmed]
McCullough PA: Renal safety of iodixanol. Expert Rev Cardiovasc Ther. 2006 Sep;4(5):655-61. [Pubmed]
External Links
Wikipedia
Drugs.com
Sigma Aldrich - D1556 external link
Frequently Asked Questions
Live Chat and Frequently Asked Questions are available for this Product.
Application
Density gradient suitable for isolation of cells and cell organelles, virus purification, and isolation of lipoproteins and macromolecules.
Other Notes
60% (w/v) solution of iodixanol in water (sterile).
法律信息
OptiPrep is a trademark of Axis-Shield PoC AS
Toronto Research Chemicals - I667200 external link
Nonionic, dimeric x-ray contrast medium. Diagnostic aid (radiopaque medium).

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • • McCullough PA: Renal safety of iodixanol. Expert Rev Cardiovasc Ther. 2006 Sep;4(5):655-61. Pubmed
  • • Spencer CM, Goa KL: Iodixanol. A review of its pharmacodynamic and pharmacokinetic properties and diagnostic use as an x-ray contrast medium. Drugs. 1996 Dec;52(6):899-927. Pubmed
  • • Svaland, M.G., et al.: Invest. Radiol., 27, 130 (1992)
  • • Palmers, Y., et al.: Eur. J. Radiol., 17, 203 (1992)
  • • Conroy, R.M., et al.: Clin. Radiol., 49, 337 (1992)
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle